I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Jourdain, Hugo
39
results:
Search for persons
X
Format
Online (39)
Mediatypes
E-Books (1)
Articles (Online) (10)
Bookchapter (Online) (1)
OpenAccess-fulltext (27)
Languages
english (37)
french (2)
Sorted by: Relevance
Sorted by: Year
?
1
Persistence and safety of anti-TNF biosimilars versus origi..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
RMD Open. 10 (2024) 1 - p. e003531 , 2024
Link:
https://doi.org/10.1136/..
?
2
Severe Hypersensitivity Reactions at Biosimilar versus Orig..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
BioDrugs. 37 (2023) 3 - p. 397-407 , 2023
Link:
https://doi.org/10.1007/..
?
3
Drug survival and safety of biosimilars and originator adal..:
Phan, Duc Binh
;
Jourdain, Hugo
;
González-Quesada, Alicia
...
BMJ Open. 13 (2023) 7 - p. e075197 , 2023
Link:
https://doi.org/10.1136/..
?
4
Roll-out and effectiveness of HIV pre-exposure prophylaxis ..:
Billioti de Gage, Sophie
;
Jourdain, Hugo
;
Desplas, David
.
Therapies. 78 (2023) 5 - p. 585-591 , 2023
Link:
https://doi.org/10.1016/..
?
5
Real-world effectiveness of pre-exposure prophylaxis in men..:
Jourdain, Hugo
;
de Gage, Sophie Billioti
;
Desplas, David
.
The Lancet Public Health. 7 (2022) 6 - p. e529-e536 , 2022
Link:
https://doi.org/10.1016/..
?
6
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
Scientific Reports. 12 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
7
Drug survival and safety of biosimilars and originator adal..:
Phan, Duc Binh
;
Jourdain, Hugo
;
González-Quesada, Alicia
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351260/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
9
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
10
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
11
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-022-24050-7. , 2022
Link:
https://hal.u-pec.fr/hal..
?
12
Characteristics of patients aged 75 years and over recurren..:
Jourdain, Hugo
dumas-03735817. , 2022
Link:
https://dumas.ccsd.cnrs...
?
13
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Jourdain, Hugo
;
Hoisnard, Léa
;
Sbidian, Emilie
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666557/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
Drug survival and safety of biosimilars and originator adal..:
Mark Lunt
;
R B Warren
;
Zenas Z N Yiu
...
https://bmjopen.bmj.com/content/13/7/e075197.full. , 2023
Link:
https://doi.org/10.1136/..
?
15
TNF-alpha inhibitors biosimilar use in France: a nationwide..:
Hugo Jourdain
;
Léa Hoisnard
;
Emilie Sbidian
.
https://doi.org/10.1038/s41598-022-24050-7. , 2022
Link:
https://doi.org/10.1038/..
1-15